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A variety of virulence genes are associated with Escherichia coli mediated urinary tract infections. Particular sets of virulence
factors shared by bacterial strains directing them through a particular pathogenesis process are called a ‘‘pathotype.’’ Comparison
of co-occurrence of potential urinary tract infection (UTI) virulence genes among different E. coli isolates from fecal and UTI col-
lections provides evidence for multiple pathotypes of uropathogenic E. coli, but current understanding of critical genetic differences
defining the pathotypes is limited. Discovery of additional E. coli genes involved in uropathogenesis and determination of their dis-
tribution and co-occurrences will further define UPEC pathotypes and allow for a more detailed analysis of how these pathotypes
might differ in how they cause disease.
 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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Escherichia coli are a very diverse species of bacteria
found naturally in the intestinal tract of all humans
and many other animal species. A subset of E. coli
are capable of causing enteric/diarrhoeal disease, and
a different subset cause extra-intestinal disease, includ-
ing urinary tract infection (UTI). The determination of
six different E. coli ‘‘pathotypes’’ that cause enteric/
diarrhoeal, enteropathogenic E. coli (EPEC), entero-
hemorrhagic E. coli (EHEC), enterotoxigenic E. coli
(ETEC), enteroaggregative E. coli (EAEC), enteroinva-
sive E. coli (EIEC) and diffusely adherent E. coli
(DAEC), greatly enhanced our understanding of path-0378-1097/$22.00  2005 Federation of European Microbiological Societies
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E-mail address: cfmarrs@umich.edu (C.F. Marrs).ogenic E. coli. Each pathotype causes disease using dif-
ferent combinations of virulence factors, with different
molecular pathways, and in some but not all cases
resulting in disease symptoms that can be distinguished
from each other (for review see [1]). This improved
understanding of E. coli causing enteric/diarrhoeal
disease has been very useful relative to therapeutic
and vaccine development.
By contrast, pathotypes have yet to be distinguished
for UTI, although by analogy, a designation uropatho-
genic E. coli (UPEC) is in common usage. UTIs are one
of the most frequently acquired bacterial infections [2]
and E. coli accounts for as many as 90% of all UTIs seen
among ambulatory populations [3]. Overall, approxi-
mately half of all women have had a UTI by their late
20s [2]. About 20–30% of women with first UTI will
have two or more infections [4]; and, for 5%, chronic
recurring infections which greatly disrupt a womans life. Published by Elsevier B.V. All rights reserved.
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rect costs of UTI in 1995 were estimated to be $1.6 bil-
lion as the result of urinary infections suffered by an
estimated 11.3 million women [2].
A UTI is defined as a significant number of patho-
genic organisms in the urinary system. If symptoms,
such as painful or frequent urination or blood in the ur-
ine, are present, as few as 100 uropathogenic bacteria
per milliliter urine may be considered significant [6].
Bacteria can be detected at high concentrations in the
urinary tract in individuals during routine urine exami-
nation. However, many of these individuals experience
no symptoms. This condition is termed asymptomatic
bacteriuria (ABU). Cases of symptomatic bacteriuria
are classified either as cystitis (CY) when infection is lim-
ited to bladder or pyelonephritis (PY) when the kidney
is infected [7]. While cystitis in the otherwise healthy
individual generally resolves without sequelae, pyelone-
phritis can cause serious morbidity and can be fatal. Pa-
tients with abnormal or obstructed urinary tracts or
with compromised immune systems are at high risk of
UTI. These infections are often referred as complicated
UTIs. There is an increased risk in this group that a sim-
ple urinary tract infection may progress to systemic
infection.
Unlike enteric/diarrhoeal diseases that often occur in
clear epidemiologic clusters, UTI epidemics are, as yet,
difficult to identify. The high background rate of UTI
[2], the impression that UTI among ambulatory patients
is caused solely by auto-infection, and the great diversity
of E. coli obscures potential epidemics. To the best of
our knowledge, only one UTI outbreak has been
reported among ambulatory patients. In Greater Copen-
hagen, Olesen et al. identified a cluster of multi-resistant,Table 1
Putative uropathogenic E. coli (UPEC) virulence factors and proposed func
Genes (virulence factor) Function or homology
cnf1 (cytotoxic necrotizing factor 1) Causes multinucleation and roundin
cvaC (colicin V) Colicin
drb (Dr family of adhesins) Adherence factors that bind decay a
fim (type 1 pili) Adherence to uroepithelial cells and
hly (a-hemolysin) Lyses red blood cells
hra (heat-resistant agglutinin) Adherence factor
iha (IrgA homolog adhesin) Adherence factor
iroNE. coli (IroNE. coli) Siderophore receptor
iucD (aerobactin) Siderophore that binds iron
kpsMT (group II capsule) Capsular polysaccharide production
ompT (OmpT) Outer membrane protease
papGAD/IA2 (class II P-pili) Adherence to uroepithelial cells
prsGJ96 (class III P-pili) Adherence to uroepithelial cells
picU (PicU) Homolog to Pic (protein involved in
sat (Sat) Serine protease autotransporter toxin
sfa (S-fimbrial family) Adherence factors
usp (uropathogen specific protein) Bacteriocin
vat (Vat) Vacuolating autotransporter toxin
PaiIIcft073 Multiple genes
a Due to space limitations, only up to three references purporting UTI virlactose-negative Escherichia coli O78:H10 causing uri-
nary symptoms among 14 community members. Only
the unusual lactose-negative phenotype made the cluster
visible [8]. This lack of epidemiologic clusters has made
it much more difficult to determine if there are separate
pathotypes of UPEC.
Several recent reviews give detailed overviews of
UPEC pathogenesis factors [1,9–12]. Here, we present
a brief summary of what is currently known about
UPEC virulence genes, and then examine the evidence
for the existence of distinct UPEC pathotypes with dif-
ferent sets of virulence genes that help determine the spe-
cific E. coli–host interactions that lead to urinary tract
infections.2. Summary of currently studied UPEC virulence genes
Table 1 presents a set of E. coli genes that have been
potentially implicated as important in allowing some
UPEC isolates to establish urinary tract infections.
The first one we will discuss is the fim gene cluster that
encodes the proteins responsible for type 1 pilus produc-
tion. Unlike the other genes in Table 1, the fim genes are
not present in a statistically significantly higher set of
UPEC vs. rectal isolates as almost all E. coli have the
fim genes. However, as is true with many of the pilus
gene clusters in E. coli, type 1 pilus expression is regu-
lated in part by a phase-variation system. Gunther IV
et al. [19] compared the fate of mutants phase-locked
in either the on or off configuration in a mouse model
of ascending urinary tract infection and found that the
locked-off mutants were recovered from the urine, blad-
der and kidneys 24 h post-inoculation in significantlytion or homology
Referencea
g of human cells [13–15]
[16]
cceleration factor (DAF) [13,17,18]
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mutants were recovered at higher numbers than the wild
type, implying an important role for type 1 pili in initial
colonization of the bladder. In addition to mediating
adherence to bladder epithelium, the FimH adhesin at
the tip of type 1 pili mediate invasion of bladder epithe-
lial and mast cells into caveolae [20,21], which has been
proposed to protect the bacteria from host defenses and
antibiotics. This may explain the observation that
roughly one half of all second UTIs are caused by the
same E. coli strain that caused the initial UTI [41,42].
One of the most studied groups of UTI virulence fac-
tors is the P-fimbrial adhesins that mediate attachment
to the P-blood group antigens on uroepithelial cells.
The P-fimbrial-tip adhesin is encoded by the papG gene,
and four classes of these adhesin genes have been de-
scribed that have between 45% and 65% homology to
each other at the amino acid level [30]. Only two of these
four classes, papGAD/IA2 (class II) and prsGJ96 (class III),
are clearly associated with uropathogenicity [13,30].
Class II adhesin genes are found predominantly among
pyelonephritis isolates, while class III adhesin genes oc-
cur somewhat more frequently among cystitis isolates
than among pyelonephritis isolates [13]. Colonization
studies of human volunteers with isogenic strains with
and without either class II or class III P fimbriae have
demonstrated that P fimbriae improve E. coli coloniza-
tion of the bladder and also increase the host immune
response to the bacteria [10]. P fimbriae trigger the
Toll-like receptor 4 pathway for host cell activation [43].
The Dr family of adhesins share a common receptor,
the Dr blood group antigen component of decay-acceler-
ating factor [17]. This widely distributed receptor along
the urinary tract may underline the potential importance
of Dr adhesin-producing E. coli in ascending coloniza-
tion of the urinary tract. Dr adhesins occur more fre-
quently among E. coli cystitis isolates than fecal
isolates [13]. We also found the presence of Dr at time
of first UTI is associated with an increased risk of second
UTI [41]. In general there are no significant difference in
the prevalence of Dr adhesins in pyelonephritic isolates
when compared to fecal isolates [13]; however, Goluszko
et al. [18] found that 30–40% of E. coli isolates from preg-
nant women with pyelonephritis had Dr operons.
S fimbriae of E. coli bind to sialyl galactosides and
are implicated in experimental UTI in rats [44]. UTI iso-
lates are at least two times more likely to carry S fimb-
riae genes than fecal isolates [13,35]. More recently,
two additional potential adherence factors, encoded by
the genes hra and iha, were associated with UPEC iso-
lates. The hra gene was found in 43–58% of cystitis iso-
lates, and in 66% of pyelonephritis isolates, compared to
just 28% of rectal isolates [24]. There are mixed reports
on the potential importance of iha. Kanamaru et al. [25]
compared 194 cystitis, and 76 pyelonephritis isolates to
50 fecal isolates from healthy adults and found iha pres-ent in 39% of cystitis, 45% of pyelonephritis, and only
12% of fecal isolates. Johnson et al. [26] looked at the
prevalence of iha in a variety of E. coli, finding it present
in 13/77 (17%) of fecal isolates from healthy women, 34/
156 (22%) of cystitis isolates from women, 97/170 (57%)
of pyelonephritis isolates from women, and 25/48 (52%)
of pyelonephritis isolates from children, where the later
two sets were statistically significantly different from the
fecal frequencies. By contrast, Bauer et al. [27] found iha
in 64/184 (35%) of fecal isolates from healthy women,
129/355 (36%) of cystitis isolates from women, and 61/
153 (40%) of pyelonephritis isolates from children, with
no significant differences between the fecal isolates
and the UTI ones. Clearly, the major difference between
the Kanamaru et al. and Johnson et al. reports and the
Bauer et al. one is in the frequency of iha in the fecal iso-
lates from healthy women, something that future studies
may resolve. Johnson et al. [26] also have shown that an
iha deletion mutant of CFT073 is out competed by
CFT073 in the mouse model of ascending UTI.
Toxins are important virulence factors in a variety of
E. coli mediated diseases. Production of toxins by colo-
nized E. coli may cause an inflammatory response, a
possible pathway for UTI symptoms. Two toxins associ-
ated with uropathogenic E. coli are a-hemolysin (HlyA)
and cytotoxic necrotizing factor 1 (CNF1). In 1991,
OHanley et al. reported that a-hemolysin was corre-
lated with septicemia and renal damage in a mouse
model of pyelonephritis [22]. In 1993, Ikaheimo et al.
[23] reported that E. coli isolated from women with cys-
titis were hemolytic 22.5% of the time, while only 10.8%
of stool isolates were hemolytic. Using hybridization to
an hly gene probe, we found a significant difference in
the presence of hly between various UTI (31–48%) and
fecal (15%) isolates [13]. CNF1 is also found more often
in UTI strains than in fecal strains [13]. Caprioli et al.
[14] examined 91 UTI isolates and determined that
37% produced both CNF1 and hemolysin, while among
114 isolates from normal stools only 1 (0.9) produced
CNF1. E. coli cnf1 mutants compared to their isogenic
cnf1+ parents have decreased virulence in a mouse
model of ascending UTI [15]. Using hybridization to a
cnf1 gene probe we found a significant difference in the
presence of cnf1 between various UTI (27–41%) and
fecal (9%) isolates [13]. Sat, a vacuolating cytotoxin,
elicits defined damage to kidney epithelium during
upper urinary tract infection [34]. Using a sat gene
probe, Guyer et al. [33] found 38 out of 67 (55%) pyelo-
nephritis isolates but only six out of 27 (22%) fecal
isolates carried the sat gene.
In addition to the sat gene, two other serine protease
autotransporter genes are associated with urinary tract
infection isolates of E. coli, picU and vat [31,37,38]. PicU
has mucinolytic activity [31], while Vat is a vacuolating
autotransporter toxin originally found in avian patho-
genic E. coli [37].
186 C.F. Marrs et al. / FEMS Microbiology Letters 252 (2005) 183–190Several of the potential virulence factors listed in Ta-
ble 1 are associated with iron uptake systems. The sider-
ophore aerobactin is synthesized by a set of iuc genes
and proteins encoded by iut genes mediate its transport.
When we used an iucD gene probe, we found the preva-
lence in our cystitis collections varied between 33% and
46%, which was not statistically different from the 41%
found in our fecal isolates [13]. However, iucD occurred
in a statistically significantly larger percentage (69%) of
our pyelonephritis isolates [13]. Further, Torres et al.
[29] reported that an iutA mutant of CFT073 is out com-
peted by CFT073 in a mouse model of ascending urinary
tract infection. A screen of genes upregulated when the
UPEC strain CP9 was grown in urine identified the iro-
NE. coli, which encodes a siderophore receptor, as a gene
whose expression increased 27-fold [28] The iroNE. coli
gene occurs consistently more frequently in both cystitis
and pyelonephritis isolates compared to fecal isolates
[13,25,27]. Three additional genes with homology to
iron uptake systems have been reported by Rasko
et al. [39] to be present more often in E. coli cystitis or
pyelonephritis isolates compared to fecal ones, and Par-
ham et al. [40] have shown that these fbp genes are more
common in prostatitis isolates than in cystitis or pyelo-
nephritis isolates.
The genes for group II capsule formation (kpsMT)
and outer membrane protein T (ompT), which is a pro-
tease, are fairly common in fecal E. coli, but are still sta-
tistically significantly more often in UPEC isolates
[13,25]. Two bacteriocin genes, usp [36] and cvaC [16],
have been implicated as potential UPEC virulence
genes. The evidence is strongest for usp, which is most
prevalent in pyelonephritis isolates, but is also present
in cystitis isolates at a higher frequency than in fecal iso-
lates [25,27]. Currently, the evidence for cvaC is only
suggestive, as cvaC was found in 15.3% of pyelonephritis
isolates, 9.1% of cystitis isolates, and 6.8% of asymp-
tomatic bacteriuria isolates; the sample size was too
small for these differences to be statistically significant.
Finally, two additional open reading frames present
in pathogenicity island II of CFT073 with similarities
to transposase genes are more common in UTI isolates
than in fecal isolates [39], and this same pathogenicity is-
land II has three genetic loci statistically significantly
more often in prostates than in pyelonephritis [40].3. Are there distinct UPEC pathotypes?
Individual genes or even clusters of genes encoding a
single complete virulence factor are not by themselves
sufficient to allow bacteria to cause disease. Rather,
complementary sets of virulence factors work together
to direct bacteria through a particular interaction with
the host that can result in disease. Strains of a given bac-
terial species that have a particular set of virulence fac-tors in common that direct them through a particular
pathogenesis process are called a ‘‘pathotype.’’ As men-
tioned earlier, E. coli causing enteric/diarrhoeal disease
can be grouped into at least six different pathotypes.
What is the evidence that E. coli causing UTIs may also
be made up of distinct pathotypes?
Previous studies by our group demonstrate that
E. coli causing first UTI have many different constella-
tions of virulence factors. Among 216 E. coli causing
first UTIs, grouping by the presence of nine known uro-
pathogenic factors led to 36 distinct groups; using
Southern analysis, these 36 groups could be divided into
at least 125 different strains [45]. These different constel-
lations predict different risks of acquiring a second UTI
in the following 6 months [41]. Further, certain O sero-
groups are found more frequently in UTI than in fecal
isolates, but a wide array of O serotypes are found
among UTI strains [46]. While this diversity may suggest
that any E. coli can cause UTI, this is not the case:
UPEC can be differentiated from rectal E. coli based
on a number of parameters including the presence of
known virulence factors. Based on these observations,
we hypothesize that UTI has multiple molecular path-
ways that may contribute to pathogenesis.
We screened our E. coli isolates from first UTI, sec-
ond UTI, recurring UTI, UTI in women aged 40–65
years, pyelonephritis in young children, periurethral,
and rectal isolates for the presence or absence of 10 vir-
ulence genes [13], and created a binary score or ‘‘viru-
lence signature’’. Excluding type 1 pili, which are
present in virtually all E. coli isolates in our collection,
there are 512 possible virulence signatures. However,
we observed six virulence signatures that contain over
one half of all strains from each collection (UTI case,
urinary, vaginal, rectal, etc.), with the distribution of
these signatures varying by whether the isolates are uri-
nary, periurethral, or rectal flora. In addition, a com-
mon virulence signature from one source (i.e., first
UTI) is often found at much lower levels in isolates from
another source (i.e., rectal). This conforms to the above
model of diverse pathotypes of E. coli within the clinical
syndrome we call UTI.
Using our previously published data on presence or
absence of 10 virulence genes [13], we examined the
co-occurrence of these virulence genes among 762 of
the isolates. As several gene combinations occurred to-
gether more frequently than predicted by chance alone,
we decided to classify isolates based on the association
between genes. We examined the associations between
all genes tested by collection, and defined those with
the strongest associations combined with known bio-
logic evidence for physical linkage as a pathotype. The
associations between all genes were retested excluding
the already identified pathotype isolates. This process
was repeated until no obvious groupings remained.
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collections, consistent with their known joint mapping
to the PAI V pathogenicity island in J96 [47]. PAI V also
contains the prsGJ96 gene. Because of this association
with a potentially important UTI PAI, we define strains
that are cnf 1þhlyþprsGþJ96 as pathotype 1.
After removing pathotype 1 strains from the analysis,
cnf1 and hly are still strongly associated with each other
(Table 2), and with sfa as well (data not shown). Further,
hly also appears to be associated with papGAD/IA2, an
association that does not exist when all isolates are com-
pared (Table 2). Therefore, we defined all strains that
were cnf1+hly+sfa+, after the removal of pathotype 1
strains, as pathotype 2 strains. The strains containing
cnf1 are almost always grouped as either pathotype 1
or pathotype 2. When the pairwise association analysis
was performed on the remaining strains after removal
of both pathotype 1 and 2 strains, hly was positively
associated with papGAD/IA2 at a level that reaches statis-
tical significance in each of the collections (Table 2).
We sequentially defined a total of five pathotypes
using this strategy (Table 3). The groups are hierarchi-
cal: pathotype 1 takes precedence over pathotype 2 and
so forth. Pathotypes 1–4 occur in at least two of the
UTI collections at two or more times the frequency
with which they are found in fecal isolates. This was
expected based on the UTI specificity of the individual
genes used to define them. In addition, the distribution
of pathotype strains among the different collections
differs from that expected by chance alone
(p = 2.0 · 1010).
Four of the five pathotypes occurred more frequently
in the UTI than fecal isolates. These first four patho-
types account for most of the previously described uri-
nary E. coli virulence genes. Pathotype 5 differs in
several important respects. It is defined by the presence
of two commonly occurring genes, kpsMT and ompT, in
the strains remaining after the four UTI enriched path-
otype strains are removed from analysis. Pathotype 5
strains made up about 37% of all isolates we analyzed,
and occurred in a slightly higher percentage of fecal than
UTI isolates. We hypothesize that pathotype 5 strains
are a combination of different pathotypes, some pre-
dominantly UTI and others mainly fecal, that we cannot
distinguish using current probes. To break pathotype 5
into UTI vs. fecal pathotypes we need additional
E. coli genes found primarily in either UTI or fecal path-
otype 5 isolates.
In women aged 18–39 with first UTI, there were no
statistically significant differences in bacterial count,
hematuria, specific gravity or pH by pathotype. How-
ever, pyuria and the self-reported symptoms of back
pain and chills occurred more often in women with first
UTI infected with E. coli pathotype 3 (aer+, hly+,
papGþAD=IA2). There was also a statistically significant






























































































































































































































































































































































































































































































































188 C.F. Marrs et al. / FEMS Microbiology Letters 252 (2005) 183–190found in white versus black women with first UTI, with
pathotypes 1, 3 and 4 being more common in isolates
from black women.
While we feel existing evidence is good that separate
UPEC pathotypes exist, it is very clear that we have a
very limited current understanding of the critical genetic
differences that truly define the different pathotypes.
Equally importantly, use of current known virulence
factors to create potential pathotypes has not yet given
the resolution needed to match specific potential patho-
types with clinical characteristics of disease. Discovery
of additional E. coli genes involved in uropathogenesis
anddeterminationof their distribution and co-occurrences
will help further define UPEC pathotypes and allow for a
moredetailedanalysis of howthesepathotypesmightdiffer
in how they cause disease.4. Concluding remarks
Being able to identify particular pathotypes of a bac-
terial species has proved very helpful in understanding
the particular disease processes involved and in identify-
ing particular virulence factors for therapeutic or vac-
cine development. Clearly, we need to determine the
distributions of many potential UPEC virulence genes,
both those listed in Table 1 and others as they are dis-
covered, in large collections of epidemiologically well
defined collections of both fecal and rectal E. coli com-
pared to the various categories of UTI isolates. This
process will be facilitated by the existence of a complete
genome sequence for the pyelonephritis strain CFT073
[48], and by using high throughput screen methods such
as the Library on a Slide approach we have recently
published [49].Acknowledgements
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